Although the tumour-suppressive function of LOXL4 has been documented in bladder cancer, hepatocellular carcinoma, prostate cancer, and breast cancer, its role in other types of tumours remains ambiguous and warrants further exploration. The gene discussed is LOXL4; the disease is breast cancer.